Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement

Bias reduction of maximum likelihood estimates

David Firth · Biometrika · 1993 · 4.4K citations

Business, Biostatistics, Bayesian Biostatistics +16

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.

Brodeur Gm, Jon Pritchard, Frank Berthold et al. · PubMed · 1994 · 392 citations

Medicine, Oncology, Surgery +6

A Solution to the Problem of Monotone Likelihood in Cox Regression

Georg Heinze, M. Schemper · Biometrics · 2001 · 367 citations · Full text

Public Health, Biostatistics, Epidemiologic Methods +16

Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study

Daphne A. Haas‐Kogan, Patrick S. Swift, Michael T. Selch et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 172 citations

Medicine, Oncology, Radiation Oncology +10